Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
Summary Chronic liver diseases, including cirrhosis and liver failure, remain formidable challenges due to their complex progression and limited therapeutic options. Mesenchymal stem cell (MSC) therapy has emerged as a game-changing approach, leveraging its potent immunomodulatory, anti-fibrotic, an...
Saved in:
Main Authors: | Wei-Chen Huang, Yuan-Chi Li, Pin-Xuan Chen, Kevin Sheng-Kai Ma, Li-Tzu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-024-04127-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer
by: Lulu Sun, et al.
Published: (2024-12-01) -
Effect of mesenchymal stem cells on animal semen during storage
by: E. Yu. Zakirova, et al.
Published: (2023-12-01) -
A General Overview of Mesenchymal Stem Cell Therapies in Drug- and Chemical-Induced Liver Injury Models
by: Müşerref Şeyma Ceyhan, et al.
Published: (2024-04-01) -
Exosomes derived from liver failure patients’ plasma stimulated mesenchymal stem cells alleviate acute liver failure
by: Zhuoran Wang, et al.
Published: (2025-02-01) -
Forgettable in the care of liver cirrhosis: the unseen culprits of progression from bad to worse
by: Maha Elsabaawy, et al.
Published: (2024-03-01)